In a patient on irbesartan 300 mg daily and amlodipine 5 mg daily, who discontinued hydrochlorothiazide due to hyponatremia (serum sodium 134 mmol/L) and has persistently elevated blood pressure, can the amlodipine dose be increased?

Yes, you can increase amlodipine to 10 mg daily in this patient

Given the patient's sodium level of 134 mmol/L (which is within acceptable range) and uncontrolled blood pressure on irbesartan 300 mg plus amlodipine 5 mg daily, increasing amlodipine to 10 mg daily is the appropriate next step. This follows the standard hypertension treatment algorithm and avoids reintroducing thiazide diuretics that caused hyponatremia.

Rationale Based on Guidelines

The 2020 International Society of Hypertension guidelines provide clear direction for this scenario 1. The treatment algorithm for non-Black patients specifies:

1. Start with low-dose ARB (irbesartan) - already at maximum 300 mg
2. Add DHP-CCB (amlodipine) - currently at 5 mg
3. Increase to full dose - this is your current step
4. Then add thiazide/thiazide-like diuretic if still uncontrolled

Your patient is currently at step 2-3, so increasing amlodipine to the maximum dose of 10 mg daily is guideline-concordant before considering other options 1.

Sodium Level Considerations

The patient's sodium of 134 mmol/L is technically just below the normal range (typically 135-145 mmol/L), but this is not a contraindication to increasing amlodipine. Here's why:

• Amlodipine does not cause hyponatremia. In fact, research shows amlodipine may actually cause mild natriuresis (sodium loss in urine) and slightly reduce total body sodium, but this does not translate to clinically significant hyponatremia 2.

• The 2001 European Heart Failure guidelines note that serum sodium <135 mmol/L warrants specialist referral in heart failure patients 3, but your patient doesn't have heart failure—this was related to diuretic use.

• The sodium level of 134 mmol/L represents mild hyponatremia that was likely thiazide-induced and should improve after HCTZ discontinuation 4, 5, 6, 7, 8.

Evidence Supporting Amlodipine Dose Increase

Direct comparative research supports this approach. A 2018 prospective study specifically compared increasing amlodipine from 5 mg to 10 mg versus adding indapamide in patients uncontrolled on ARB plus amlodipine 5 mg 9. The study found:

• Both regimens effectively reduced blood pressure
• Increasing amlodipine to 10 mg produced greater systolic BP reduction at 1 month and 6 months (p<0.05)
• The amlodipine group avoided the uric acid elevation seen with indapamide addition
• No significant adverse effects with higher-dose amlodipine

The FDA label confirms amlodipine can be safely increased to 10 mg daily, with dose-dependent BP reductions and peak effects at 3-6 hours 10. The maximum approved dose is 10 mg daily for hypertension 10.

Why Not Retry a Diuretic Now?

While guidelines suggest adding a thiazide-like diuretic as the next step after maximizing ARB+CCB 1, you haven't yet maximized the CCB dose. Additionally:

• Thiazide-induced hyponatremia risk is substantial: Recent population-based data shows 2-year cumulative incidence of hyponatremia (Na <130) is 3.51-3.83% with thiazides, with hazard ratios of 3.56-4.25 in the first 30 days 7.

• Your patient already demonstrated thiazide intolerance with HCTZ-induced hyponatremia 4, 5, 6.

• Chlorthalidone carries even higher hyponatremia risk than HCTZ at equal doses (OR 2.09 for 12.5 mg, OR 1.72 for 25 mg) 4.

• The patient's baseline sodium of 134 mmol/L suggests ongoing vulnerability to further sodium depletion.

Practical Implementation

Increase amlodipine from 5 mg to 10 mg once daily. According to the FDA label, this can be done as a single step increase 10. The 2016 Canadian guidelines support this approach, noting that additional antihypertensive drugs should be used if target BP isn't achieved with standard-dose monotherapy, and doses should be optimized before adding agents 11.

Monitor the following:

• Blood pressure response within 2 weeks (steady state achieved in 7-8 days per FDA label 10)
• Repeat sodium level in 1-2 weeks to ensure stability or improvement
• Watch for amlodipine side effects (peripheral edema, headache, flushing)

If BP remains uncontrolled after 4-8 weeks on irbesartan 300 mg + amlodipine 10 mg:

• Consider adding a thiazide-like diuretic (indapamide or chlorthalidone preferred over HCTZ) at the lowest effective dose
• Monitor sodium closely (baseline, then at 5-7 days, 2 weeks, and monthly initially) 3, 7
• Alternatively, consider spironolactone 25 mg if sodium normalizes and potassium/renal function permit 1, 12

Key Pitfalls to Avoid

1. Don't add a diuretic before maximizing amlodipine dose—you're not following the treatment algorithm correctly if you skip this step
2. Don't assume sodium of 134 mmol/L is "normal enough" to retry HCTZ—this patient has demonstrated susceptibility
3. Don't use high-dose thiazides if you do add one later—start with indapamide 1.25-2.5 mg or chlorthalidone 12.5 mg, not HCTZ 25-50 mg
4. Don't forget to recheck sodium after any medication change, especially if reintroducing diuretics

The 2024 ESC guidelines emphasize that if BP remains uncontrolled on two-drug therapy, escalation to three drugs (RAS blocker + CCB + thiazide/thiazide-like diuretic) is recommended 12, but only after optimizing the two-drug combination first.